Vardenafil (Levitra/Staxyn) Cost in Arkansas: 2026 Prices, Insurance, and Savings

Vardenafil is the generic name for the oral phosphodiesterase type 5 (PDE5) inhibitor sold under the brand names Levitra (film-coated tablet) and Staxyn (orally disintegrating tablet, or ODT). It is FDA-approved, prescription-only, and used to treat erectile dysfunction. Staxyn is not interchangeable tablet-for-tablet with Levitra or generic vardenafil film-coated tablets; the ODT formulation has different absorption characteristics and dosing rules.

The direct answer for an Arkansas reader: vardenafil's out-of-pocket cost is driven far more by which pharmacy and payment pathway you use (cash discount card, commercial insurance tier, Medicaid prior authorization, or a 503A compounding pharmacy) than by anything specific to Arkansas as a state. Arkansas Medicaid requires prior authorization for vardenafil, commercial insurers commonly apply quantity limits and step therapy toward generic sildenafil first, and compounded vardenafil is legal here through state-licensed 503A pharmacies. Specific dollar figures below change often and are not verified against a live pricing feed for this draft; treat them as illustrative starting points, not quoted prices.

The useful question isn't "what does vardenafil cost in Arkansas" but "which cost pathway applies to you"

A single "Arkansas price" for vardenafil does not really exist. Four different patients filling the same prescription at the same pharmacy chain can pay four different amounts depending on whether they are uninsured and paying cash, on a commercial plan with a specific formulary tier, on Arkansas Medicaid with an approved prior authorization, or using a manufacturer or discount-card program. The rest of this page is organized around those pathways rather than around a single price point, because that is the decision structure that actually determines what you pay.

What is established, what is plausible, and what needs verification

Established (stable, low volatility):

• Vardenafil is FDA-approved for erectile dysfunction and is prescription-only nationwide, including in Arkansas.
• Staxyn (ODT) and film-coated vardenafil tablets are distinct formulations with different handling and dosing instructions; they are not automatically substitutable.
• Compounding of vardenafil by a state-licensed 503A pharmacy, under a patient-specific prescription, is permitted under the FDA's Section 503A framework.
• Generic drugs, including generic vardenafil, must meet FDA bioequivalence standards for the active ingredient, though inactive ingredients (fillers, dyes, coatings) can differ between manufacturers.

Plausible but requiring current confirmation (moderate to high volatility):

• Arkansas Medicaid's prior authorization criteria, ICD-10 documentation expectations, and typical turnaround times for vardenafil specifically.
• Which commercial insurers active in Arkansas place generic vardenafil on which formulary tier, and whether step therapy toward sildenafil is required.
• Cash and discount-card prices at specific Arkansas pharmacies, which change frequently and vary by ZIP code, chain, and quantity.
• Manufacturer savings card terms and eligibility, which are typically renewed or revised annually.

Not established from the material available for this page:

• A precise, current average cash price for generic vardenafil in Arkansas. Figures such as "$120 per month" circulate in secondary sources but could not be traced to a verifiable, dated pricing dataset for this draft.
• Arkansas-specific data on how often formulary exceptions succeed, or exact percentages of plans using step therapy.
• Any claim that vardenafil works faster, more reliably, or with better tolerability than sildenafil or tadalafil for a given individual. Comparative response to PDE5 inhibitors is individual, and no source reviewed here supports a general superiority claim for vardenafil.

Brand, generic, and Staxyn pricing: what to expect and what to verify

Manufacturer list prices for brand-name Levitra are set by Bayer and are rarely what patients actually pay, since most fills go through generic substitution, insurance negotiation, or discount programs. Generic vardenafil, once multiple manufacturers entered the market, typically costs substantially less than the brand list price, consistent with the pattern seen across other PDE5 inhibitors after generic entry. The exact current gap between brand and generic cash prices in Arkansas is a date-sensitive fact you should confirm at the pharmacy counter or on a pharmacy price-lookup tool rather than rely on a figure quoted in an article.

Staxyn (the ODT formulation) has no FDA-approved generic equivalent as of this writing, which typically keeps its per-tablet cash price higher than film-coated generic vardenafil. Patients who need the ODT form for swallowing difficulty should expect a premium and should confirm the current per-tablet price directly with the dispensing pharmacy.

Because vardenafil tablets of different strengths (5 mg, 10 mg, 20 mg) are frequently priced the same per tablet by a pharmacy, some patients ask their prescriber whether a higher-strength scored tablet can be split to yield two lower-strength doses at a lower cost per dose. This is a real cost-management question worth raising with a prescriber, not a decision to make independently: Staxyn ODT cannot be split, and whether any specific film-coated tablet is scored and appropriate for splitting depends on the manufacturer and formulation.

Does Arkansas Medicaid cover vardenafil?

Arkansas Medicaid covers vardenafil under a prior authorization framework rather than open formulary access. In general, state Medicaid PA processes for PDE5 inhibitors require documentation of an erectile dysfunction diagnosis, some clinical basis for the condition, and confirmation that the patient has no contraindication such as concurrent nitrate therapy (a combination that can cause dangerous hypotension). Coverage purely for elective or recreational use is not typical of state Medicaid programs generally.

Specific processing timeframes, the exact ICD-10 documentation Arkansas Medicaid expects, and current appeal procedures are the kind of detail that changes with policy updates and should be confirmed directly with Arkansas Medicaid or the prescriber's office at the time of the request. The Centers for Medicare & Medicaid Services sets baseline federal requirements that state Medicaid programs provide fair hearing and appeal rights when a claim is denied, which is a stable federal-level fact, but the Arkansas-specific procedural details sit on top of that baseline and require separate confirmation.

Patients who are dual-eligible for Medicare and Medicaid should be aware that a Medicare Part D plan's coverage policy for PDE5 inhibitors can differ from, and may be more restrictive than, Arkansas Medicaid's own policy.

Private insurance coverage in Arkansas

Most major commercial insurers operating in Arkansas provide some coverage for generic vardenafil, but formulary tier, copay amount, quantity limits, and step-therapy requirements vary by plan and change at annual formulary updates. A plan that places generic vardenafil on a lower cost-sharing tier one year may reclassify it the next. Quantity limits (a monthly cap on the number of tablets covered) are common across PDE5 inhibitors industry-wide, though the exact figure for any single Arkansas plan needs to be checked against that plan's current formulary document rather than assumed from a general industry pattern.

Verification checklist: stable facts vs. facts you must confirm before relying on them

Use this table as a filter: anything in the "stable" rows can be treated as reliable background. Anything in the "volatile" or "not verified" rows should be confirmed the same day it will affect a purchasing or coverage decision, not taken from any article, including this one.

Compounded vardenafil in Arkansas

Compounded vardenafil dispensed by a state-licensed 503A compounding pharmacy, under a valid patient-specific prescription, is generally considered a legal product under the FDA's Section 503A compounding framework. Arkansas licenses and inspects compounding pharmacies through its state Board of Pharmacy. Reasons a prescriber might use a compounded formulation include a dose not available commercially, a combination product, an alternate delivery form such as a sublingual troche, or an allergy-friendly formulation without a specific dye or excipient present in the commercial tablet.

Compounded products are not FDA-approved in the same sense as the manufactured tablet; they are prepared under a different regulatory pathway that does not require the same premarket efficacy and stability testing. Pricing varies by pharmacy and formulation complexity, and there is no dataset available here comparing compounded vardenafil pricing to commercial generic pricing across Arkansas. Ask any compounding pharmacy for itemized pricing and confirm its current Arkansas license before relying on it.

Telehealth prescribing in Arkansas

Arkansas permits telehealth prescribing of vardenafil following a synchronous (real-time video or audio) medical evaluation that includes relevant history, a check for contraindications such as nitrate or certain alpha-blocker use, and a clinical judgment that vardenafil is appropriate. This is consistent with the general shift among urology and sexual medicine bodies toward accepting non-in-person initial evaluation for straightforward ED presentations, though the exact evaluation standard a given telehealth platform applies should be confirmed with that platform, since practices differ. HealthRX.com and several national platforms serve Arkansas patients through licensed clinicians with pharmacy fulfillment; formulary options and pricing differ between platforms and should be compared directly rather than assumed equivalent.

Discount and savings pathways

• Manufacturer or generic savings cards can lower out-of-pocket cost for commercially insured patients but generally do not apply to Medicaid or Medicare. Card terms and caps change and typically require annual re-enrollment; check the current terms before counting on a specific discount amount.
• Discount coupon platforms (for example GoodRx-style services) negotiate pharmacy-specific cash rates that change frequently, sometimes week to week. A price seen last month is not a reliable guide to today's price.
• Patient assistance programs (PAPs) through manufacturers may be available to patients under a defined income threshold; directories such as NeedyMeds or RxAssist track active programs, but eligibility and enrollment timelines vary and should be confirmed directly with the program.
• 90-day fills can lower the per-tablet price compared to 30-day fills for patients with a stable, ongoing need, though this depends on the specific pharmacy or mail-order program.

Vardenafil compared with sildenafil and tadalafil

Generic sildenafil is generally the least expensive PDE5 inhibitor at retail, and generic daily tadalafil is typically priced between sildenafil and vardenafil, which is part of why many insurance step-therapy protocols require a documented trial of sildenafil before approving vardenafil. Cost is not, however, a clinical argument for one PDE5 inhibitor over another for an individual patient. Response, side-effect profile (for example, visual disturbance is a known class effect more associated with sildenafil due to PDE6 cross-reactivity, though it does not occur in every patient), and dosing preference are the relevant clinical factors, and a documented prior treatment failure or intolerance is usually what supports an insurer exception request for a non-preferred PDE5 inhibitor like vardenafil.

What affects your final out-of-pocket price

Four variables interact to determine what any individual Arkansas patient actually pays: insurance status (cash versus commercial versus Medicaid), where the patient is in their deductible cycle, which specific pharmacy is used (cash prices for identical generic drugs are known to vary meaningfully even within the same metro area, though the exact spread for vardenafil in Arkansas specifically has not been verified for this page), and the prescribed strength and quantity relative to actual use. None of these can be reduced to a single number that applies to every reader, which is why the checklist above is organized around what to verify rather than a fixed price table.

When to seek urgent or in-person care instead

Erectile dysfunction can be an early marker of cardiovascular disease, diabetes, or low testosterone, and cost-shopping for a medication should not substitute for an initial clinical evaluation if ED is new, sudden, or accompanied by chest pain, unusual fatigue, or other cardiovascular symptoms. Anyone taking nitrate medications for chest pain should not take vardenafil due to a risk of dangerous blood pressure drops, and this contraindication should be reviewed with a prescriber or pharmacist regardless of how the medication is obtained.

References

• U.S. Food and Drug Administration. Drugs: resources and information. https://www.fda.gov/drugs
• U.S. Food and Drug Administration. Drug approvals and databases. https://www.accessdata.fda.gov/
• Centers for Medicare & Medicaid Services. Medicaid program information, including state fair hearing and appeal rights. https://www.cms.gov/
• American Association of Clinical Endocrinology. https://www.aace.com/

A note on this draft: earlier versions of this page contained specific dollar figures, percentages, and attributed quotations that could not be traced to a verifiable primary source. Those have been removed or converted into general, hedged statements pending confirmation. Anyone relying on this page for a coverage or purchasing decision should verify current prices, formulary status, and Medicaid policy directly with the relevant payer or pharmacy before acting.